RadNet, Inc. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
RadNet, Inc. (RDNT) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $150.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2019-03-18.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2019-03-18
- RadNet, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2016 was $150.00K, a 74.75% decline from fiscal 2015.
- RadNet, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2015 was $594.00K, a 61.58% decline from fiscal 2014.
- RadNet, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2014 was $1.55M, a 229.64% increase from fiscal 2013.
- RadNet, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2013 was $469.00K.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|
| 2016-12-31 | $150.00K 10-K · filed 2019-03-18 |
| 2015-12-31 | $594.00K 10-K · filed 2018-03-19 |
| 2014-12-31 | $1.55M 10-K · filed 2017-03-17 |
| 2013-12-31 | $469.00K 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |